Table 3.
Complications after hospitalization by COVID-19 waves
| Complications after hospitalization | First wave (n = 211) | Second wave (n = 837) | Third wave (n = 1197) | Fourth wave (n = 552) | Fifth wave (n = 464) |
|---|---|---|---|---|---|
| Bacterial infection | 44 (21.3) | 68 (8.2) | 148 (12.6) | 54 (9.9) | 38 (8.3) |
| Fungal infection | 3 (1.5) | 4 (0.5) | 17 (1.5) | 2 (0.4) | 0 (0.0) |
| Heart failure | 15 (7.3) | 12 (1.5) | 24 (2.1) | 5 (0.9) | 12 (2.6) |
| Cardiomyopathy/Myocardial infraction | 2 (1.0) | 1 (0.1) | 9 (0.8) | 5 (0.9) | 4 (0.9) |
| Thrombosis | 18 (8.7) | 7 (0.86) | 57 (4.9) | 13 (2.4) | 5 (1.1) |
| Liver dysfunction | |||||
| Mild | 40 (20.7) | 162 (20.6) | 317 (30.0) | 164 (30.2) | 167 (36.5) |
| Moderate | 23 (11.9) | 65 (8.3) | 105 (9.3) | 59 (10.9) | 81 (17.7) |
| Severe | 14 (7.3) | 30 (3.8) | 40 (3.5) | 17 (3.1) | 27 (5.9) |
| Kidney dysfunction | |||||
| Moderate | 25 (12.9) | 65 (8.3) | 165 (14.6) | 79 (14.7) | 89 (19.6) |
| Sever | 11 (5.7) | 18 (2.3) | 55 (4.9) | 18 (3.4) | 20 (4.4) |
| Hemophagocytic syndrome | 7 (3.9) | 8 (1.1) | 11 (1.1) | 6 (1.2) | 2 (0.5) |
Data are presented as n (%)